A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression

NCT04383691 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

124

Enrollment

INDUSTRY

Sponsor class

Stopped Company's business decision

Conditions

Bipolar I Depression

Interventions

DRUG: Lurasidone HCl
DRUG: Placebo

Sponsor

Sumitomo Pharma (Suzhou) Co., Ltd.

Collaborators

[object Object]